Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.69 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.69 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.69 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.69 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.69 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.69 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9803350 | 0.99 | CYP1A2 (0.69) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 | |
| SCHEMBL10522160 | 0.90 | CYP1A2 (0.68) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 | |
| SCHEMBL10927709 | 0.86 | CYP1A2 (0.86) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 | |
| SCHEMBL10528773 | 0.86 | CYP1A2 (0.51) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 | |
| SCHEMBL10506612 | 0.85 | CYP1A2 (0.81) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 | |
| SCHEMBL10930746 | 0.84 | CYP1A2 (0.95) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 | |
| SCHEMBL10508758 | 0.84 | CYP1A2 (0.95) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 | |
| SCHEMBL8879790 | 0.84 | CHRM2 (0.61) | CYP1A2CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL9803307 | 0.84 | CHRM2 (0.63) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 | |
| SCHEMBL10516871 | 0.83 | CYP1A2 (0.72) | CYP1A2CYP3A4CHRM2CHRM4CHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0346767-A2 | Use of 5,11-dihydro-6H-pyridino[2,3-b][1,4]benzodiazepin-6-one substituted in position 11 in the manufacture of a medicament for the treatment of Brady cardia and Brady arrhytmia in human and veterinary medicine | Dr. Karl Thomae GmbH (DE) | 1989-12-20 | — | — | EP | claimed |
| US-5026699-A | Antiarrhythmia agents | DR. KARL THOMAE GMBH (DE) | 1991-06-25 | — | — | US | disclosed |
| EP-0346767-A2 | Use of 5,11-dihydro-6H-pyridino[2,3-b][1,4]benzodiazepin-6-one substituted in position 11 in the manufacture of a medicament for the treatment of Brady cardia and Brady arrhytmia in human and veterinary medicine | Dr. Karl Thomae GmbH (DE) | 1989-12-20 | — | — | EP | disclosed |